Skip to Main Content

Paper Details

Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis.
Hum Pathol
6
2022
Author NameAffiliation
Ladan FazliUniversity of British Columbia
Dean A TroyerEastern Virginia Medical School
Martin E GleaveUniversity of British Columbia
Bruce J TrockJohns Hopkins Hospital School of Medicine
Lawrence D TrueUniversity of Washington
Daniel W LinUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Ian M ThompsonUniversity of Texas Health Sciences Center at San Antonio
  • 1 - 9

Datasets